A distinct class of tumor antigens called T-cell epitopes associated with impaired peptide processing (TEIPP) has been identified in tumors with transporter associated with antigen processing (TAP) deficiencies and low expression of MHC class I38–40. Here, HLA-C is linked to neoplasm.